VORTEX is a randomised phase III trial concerning post-operative radiotherapy given to adult patients with extremity soft tissue sarcoma.

VORTEX has two treatment arms comparing a two-phase conventional radiotherapy treatment with that of a single phase treatment to selectively spare normal tissue and increase limb function without compromising local control.